Literature DB >> 28583283

Subcutaneous rituximab-a meaningful advance in care.

Sarit Assouline1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28583283     DOI： 10.1016/S2352-3026(17)30079-0

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN： 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  2 in total

Review 1.  How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa.

Authors:  Satish Gopal; Thomas G Gross
Journal:  Blood       Date:  2018-05-16       Impact factor: 22.113

2.  Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases.

Authors:  Pierre Peterlin; Thierry Guillaume; Alice Garnier; Amandine Le Bourgeois; Beatrice Mahé; Viviane Dubruille; Nicolas Blin; Pierre Gallas; Cyrille Touzeau; Thomas Gastinne; Anne Lok; Patrick Thomare; Cecile Chauvin; Steven Le Gouill; Philippe Moreau; Patrice Chevallier
Journal:  Leuk Res Rep       Date:  2018-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.